Clinical trials
Completed Phase 2 Carcinoma, Squamous Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
73 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 6 |
| 2007 | 6 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 73 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UNC Lineberger Comprehensive Cancer Center | 5 |
| Amgen | 3 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2 |
| Dan Zandberg | 2 |
| Dana-Farber Cancer Institute | 2 |
| M.D. Anderson Cancer Center | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Susanne Arnold | 2 |
| UNICANCER | 2 |
| University Health Network, Toronto | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Squamous Cell | 73 |
| Head and Neck Neoplasms | 27 |
| Squamous Cell Carcinoma of Head and Neck | 24 |
| Adenocarcinoma | 8 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Neoplasm Metastasis | 5 |
| Oropharyngeal Neoplasms | 5 |
| Skin Neoplasms | 5 |
| Carcinoma | 4 |
| Esophageal Neoplasms | 4 |
Trials
Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.